Showing results (1-10 of 107) with videos related to
Sort By:
Pageof 11
Expert Opinion on Drug Delivery|May 13, 2024
Improving drug delivery to the brain: the prodrug approachKristiina M HuttunenChimia|December 9, 2023
The Role of Transporters in Future ChemotherapyJohanna Huttunen, Kristiina M HuttunenCurrent Topics in Medicinal Chemistry|June 16, 2011
Prodrugs - an efficient way to breach delivery and targeting barriersKristiina M Huttunen, Jarkko RautioJournal of Pharmaceutical Sciences|June 4, 2014
Sustained release of metformin via red blood cell accumulated sulfenamide prodrugLauri Peura, Kristiina M HuttunenInflammopharmacology|March 19, 2021
Orchestrated modulation of rheumatoid arthritis via crosstalking intracellular signaling pathwaysSherihan Salaheldin Abdelhamid Ibrahim, Kristiina M HuttunenInternational Journal of Pharmaceutics|August 28, 2018
Targeted efflux transporter inhibitors - A solution to improve poor cellular accumulation of anti-cancer agentsJohanna Huttunen, Mikko Gynther, Kristiina M HuttunenPharmacological Reviews|July 9, 2011
Prodrugs--from serendipity to rational designKristiina M Huttunen, Hannu Raunio, Jarkko RautioChemico-Biological Interactions|June 21, 2021
Hemocompatible L-Type amino acid transporter 1 (LAT1)-Utilizing prodrugs of perforin inhibitors can accumulate into the pancreas and alleviate inflammation-induced apoptosisJanne Tampio, Magdalena Markowicz-Piasecka, Kristiina M HuttunenJournal of Enzyme Inhibition and Medicinal Chemistry|September 26, 2018
Metformin and its sulphonamide derivative simultaneously potentiateanti-cholinesterase activity of donepezil and inhibit beta-amyloid aggregationMagdalena Markowicz-Piasecka, Kristiina M Huttunen, Joanna SikoraEuropean Journal of Pharmacology|July 2, 2025
Optimizing the structure of repurposed metformin can improve anti-cholinesterase and anti-amyloidogenic effectsMagdalena Markowicz-Piasecka, Tuomo Laitinen, Kristiina M HuttunenPageof 11